NCT02046291
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +24 more
- Locations
-
- University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
Clinical trial condition
Leukemia, Myeloid, Acute
Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.
78 public trials
10 recruiting studies
Leukemia, Myeloid, Acute trial results
NCT02620254
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +19 more
- Locations
-
- Registry participation is worldwide and not limited to this facility Cambridge, Massachusetts, United States
NCT04562818
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Nidia Zapata Mexico City, Mexico
NCT01869777
- Conditions
- Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +27 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
NCT00463385
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- UCLA School of Medicine Hematology/Oncology Los Angeles, California, United States
- Mayo Clinic Rochester, Minnesota, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- New York Presbyterian HospitalWeill Medical College of Cornell University New York, United States
NCT00413166
- Conditions
- Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Conditions
- Advanced Hematological Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
- Weill Cornell Medical College New York, United States
- Vanderbilt University Nashville, Tennessee, United States
- MD Anderson Houston, Texas, United States
Completed
Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
NCT01807598
- Conditions
- Aggressive Systemic Mastocytosis, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Stanford University, School of Medicine Stanford, California, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT00782067
- Conditions
- Aberrant Motor Behavior in Dementia, Aggression, Behavior, +16 more
- Locations
-
- University of California at Los Angeles Dept. of Hematology Clinic Los Angeles, California, United States
- Stanford University Medical Center Stanford University 2 Stanford, California, United States
- Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia Augusta, Georgia, United States
- Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States
NCT00233454
- Conditions
- Aberrant Motor Behavior in Dementia, Aggression, Behavior, +19 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Washington University-St. Louis St Louis, Missouri, United States